Health Cor Management, L.P. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Health Cor Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $8.2 Million - $12.2 Million	-82,183 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $7.04 Million - $9.89 Million	71,183 Added 647.12%	82,183 $11.4 Million
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $723,580 - $1.16 Million	11,000 New	11,000 $1.07 Million
Q2 2019 Aug 14, 2019	SELL	$39.79 - $67.01 $6.05 Million - $10.2 Million	-152,040 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $5.25 Million - $8.1 Million	152,040 New	152,040 $7.83 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.